(CN) — Proteins in the blood may provide key indicators of the inflammatory process that takes place in the early stages of Parkinson’s disease which is likely to allow for broader clinical trials ...
Hosted on MSN
Simple new blood test could help identify Parkinson’s patients at early stages of disease
A simple blood test may help identify people at the earliest stages of Parkinson’s disease, long before they begin to show symptoms, new research has found. The study, published on Friday in the ...
A recent study showed that changing up therapies in the later stages of Parkinson’s disease improved motor symptoms and other subjective symptoms. As a result, doctors should consider advanced therapy ...
Symptoms of Parkinson’s disease, such as tremors and stiffness, can make daily tasks difficult. A new drug has shown promise in alleviating symptoms. Tavapadon, a drug being tested to treat early ...
SHREVEPORT, La. (KSLA) - Parkinson’s disease is a progressive disorder that affects the nervous system and the parts of the body controlled by the nerves. Most cases happen for unknown reasons, but ...
A test that can detect Parkinson's disease in the early stages of the illness has moved a step closer. Scientists have developed a way of detecting a molecule linked to the condition in samples of ...
Your T cells work hard to fight disease. Unfortunately, "friendly fire" from T cells can sometimes harm the body's healthy tissues. For people with autoimmune disease, T cell reactivity is a big ...
Changes in the bacteria found in the mouth and gut of Parkinson’s disease patients could act as an early warning sign that their symptoms are worsening, new research suggests. Scientists, using ...
This Friday, Nov. 21, from 5:30 to 10 p.m., NWI Parkinson’s is hosting a 21st Anniversary Dinner and Style Show Fundraiser at Avalon Manor.
Speculation about President Biden suffering from the early stages of Parkinson's disease is intensifying. It comes from the revelation that top Parkinson's specialist Dr. Kevin Cannard, has made 10 ...
- Results from Phase IIb PADOVA and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in early-stage Parkinson’s disease - - Prasinezumab is a potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results